The leaders of the House Committee on Energy and Commerce are probing 23andMe's recent bankruptcy and its implications for customer data. In a letter to interim CEO Joe Selsavage, they raised concerns about how customer information will be managed if the company is sold. The letter highlights issues like the lack of HIPAA protections for direct-to-consumer genetic testing and reports from customers struggling to delete their data. The representatives are apprehensive that sensitive information may be compromised during the bankruptcy process and potential sale.
The House Committee on Energy and Commerce is investigating 23andMe's bankruptcy, focusing on how it will impact customer data and privacy protections.
Given the absence of HIPAA protections and inconsistent state laws, the committee expresses concern over potential risks to sensitive customer information amid potential sales.
Collection
[
|
...
]